Murad Hussain talks about how life sciences companies and healthcare providers can work with enforcement investigators to encourage a more sophisticated analysis of data. A better understanding of the data's context and meaning could lead to more nuanced fraud enforcement investigations—and, potentially, better outcomes for the targets of those investigations. This is the latest in our series: "Insights: Life Sciences" where we examine the legal issues and trends impacting the life sciences and healthcare industries.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
